Related Experiment Video
Updated: Oct 24, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Therapeutic Drug Monitoring Considerations in Pregnancy
1Department of Pathology, University of Iowa Health Care, 200 Hawkins Drive, C-671 GH, Iowa City, IA 52242, USA.
Abstract:
Physiological changes during pregnancy can impact the pharmacokinetics of medications. Due to a variety of practical and ethical factors, clinical pharmacokinetic studies are challenging to perform during pregnancy. In addition, information on fetal toxicity of drugs requires years of study. As a result, evidence-based guidance for optimizing drug dosing in pregnancy, including therapeutic drug monitoring (TDM), is currently sparse. The most complete practice guidelines are related to antiseizure medications, with data also accumulating for antipsychotic and antidepressant medications. There are many avenues for future research and clinical practice improvement for TDM in pregnancy.
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Toxicity: Risk factors
Factors Affecting Drug Response: Overview
Pharmacokinetics in Pediatric Patients: Drug Excretion